During the past decade, Rocky Mountain Blood and Marrow Transplant Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Blood and Marrow Transplant Program" #1 sponsor was "Colorado Blood Cancer Institute" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Antisoma Research" with 1 trials sponsored and "CuraGen Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Blood and Marrow Transplant Program" are "Acute Myeloid Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Multiple Myeloma" (2 trials), "Myelodysplastic Syndromes" (2 trials) and "Acute Disease" (1 trials). Many other conditions were trialed in "Rocky Mountain Blood and Marrow Transplant Program" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Blood and Marrow Transplant Program" are "Drug" (8 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Idelalisib" (2 trials), "Allogeneic hematopoietic stem cell graft using an allogeneic SCT HLA-Identical or non-identical family donor or unrelated donors" (1 trials), "Amonafide and Cytarabine" (1 trials), "Cord Blood Transplant" (1 trials) and "Daunorubicin and Cytarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Blood and Marrow Transplant Program" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Blood and Marrow Transplant Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rocky Mountain Blood and Marrow Transplant Program, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Blood and Marrow Transplant Program, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".